eIF5A2 regulates the resistance of gastric cancer cells to cisplatin via induction of EMT

Cisplatin is the first-line chemotherapy drug for gastric cancer (GC), but treatment failure often occurs due to development of resistance. The mechanism of cisplatin resistance remains a mystery. Eukaryotic translation initiation factor 5A2 (eIF5A2) is an important tumor-promoting factor and has be...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Transl Res
Autors principals: Sun, Jiancheng, Xu, Zhiyuan, Lv, Hang, Wang, Yiping, Wang, Lijing, Ni, Yixiu, Wang, Xiaofeng, Hu, Can, Chen, Shangqi, Teng, Fei, Chen, Wei, Cheng, Xiangdong
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325524/
https://ncbi.nlm.nih.gov/pubmed/30662669
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars